Impaired desensitization of a human polymorphic α2B- adrenergic receptor variant enhances its sympatho-inhibitory activity in chromaffin cells

Cell Communication and Signaling

Volumn 9, Issue , 2011, Pages

  Nguyen, Kristy ^a   Kassimatis, Theodoros ^b   Lymperopoulos, Anastasios ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b IASO GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2B ADRENERGIC RECEPTOR; BRIMONIDINE; CATECHOLAMINE; DNA; GLUTAMIC ACID; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); NICOTINE;

ARTICLE; BIOLOGICAL ACTIVITY; CATECHOLAMINE RELEASE; CELLULAR SECRETION; CHROMAFFIN CELL; CONTROLLED STUDY; DNA POLYMORPHISM; GENE DELETION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SYMPATHOINHIBITORY ACTIVITY;

EID: 79551637820     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-9-5     Document Type: Article

References (26)

1. IV International Union of Pharmacology nomenclature of adrenoceptors. DB Bylund, DC Eikenberg, JP Hieble, SZ Langer, JR Lefkowitz, KP Minneman, PB Molinoff, RR Ruffolo, U Trendelenburg, Pharmacol Rev 1994 46 121 136 7938162
2. Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes. M Philipp, L Hein, Pharmacol Ther 2004 101 65 74 10.1016/j.pharmthera. 2003.10.004 14729393 (Pubitemid 38068526)
3. Subtype-selective desensitization of alpha 2-adrenergic receptors. Different mechanisms control short and long term agonist-promoted desensitization of alpha 2C10, alpha 2C4, and alpha 2C2. MG Eason, SB Liggett, J Biol Chem 1992 267 25473 25479 1334095
4. G protein-coupled receptor kinases. JA Pitcher, NJ Freedman, RJ Lefkowitz, Ann Rev Biochem 1998 67 653 692 10.1146/annurev.biochem.67.1.653 9759500 (Pubitemid 28411141)
5. Adrenal adrenoceptors in heart failure: Fine-tuning cardiac stimulation. A Lymperopoulos, G Rengo, WJ Koch, Tr Mol Med 2007 13 503 511 10.1016/j.molmed.2007.10.005 (Pubitemid 350123195)
6. 2-Adrenoceptor Subtypes. M Brede, G Nagy, M Philipp, JB Sorensen, MJ Lohse, L Hein, Mol Endocrinol 2003 17 1640 1646 10.1210/me.2003-0035 12764077 (Pubitemid 36930476)
7. Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. A Lymperopoulos, G Rengo, H Funakoshi, AD Eckhart, WJ Koch, Nat Med 2007 13 315 323 10.1038/nm1553 17322894 (Pubitemid 46376685)
8. Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction. A Lymperopoulos, G Rengo, E Gao, SN Ebert, GW Dorn, WJ Koch, J Biol Chem 2010 285 16378 16386 10.1074/jbc.M109.077859 20351116
9. Modulation of adrenal catecholamine secretion by in vivo gene transfer and manipulation of G protein-coupled receptor kinase-2 activity. A Lymperopoulos, G Rengo, C Zincarelli, S Soltys, WJ Koch, Mol Ther 2008 16 302 307 10.1038/sj.mt.6300371 18223549 (Pubitemid 351168039)
10. Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. KM Small, KM Brown, SL Forbes, SB Liggett, J Biol Chem 2001 276 4917 4922 10.1074/jbc.M008118200 11056163
11. Chronic adrenaline treatment fails to down-regulate the Del301-303-alpha2B-adrenoceptor in neuronal cell. S Salim, AN Desai, M Taneja, DC Eikenburg, Br J Pharmacol 2009 158 314 327 10.1111/j.1476-5381.2009.00294.x 19719784
12. Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype. M Muszkat, D Kurnik, GG Sofowora, J Solus, HG Xie, PA Harris, SM Williams, AJ Wood, CM Stein, J Hypertension 2010 28 278 284 10.1097/HJH.0b013e328333d212
13. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells, which respond to nerve growth factor. LA Greene, AS Tischler, Proc Natl Acad Sci USA 1976 73 2424 2428 10.1073/pnas.73.7.2424 1065897
14. Subtype-specific stimulation of [35S] GTPgammaS binding by recombinant alpha2-adrenoceptors. JM Peltonen, M Pihlavisto, M Scheinin, Eur J Pharmacol 1998 355 275 279 10.1016/S0014-2999(98)00518-4 9760042 (Pubitemid 28404710)
15. Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. P Heinonen, M Koulu, U Pesonen, MK Karvonen, A Rissanen, M Laakso, R Valve, M Uusitupa, M Scheinin, J Clin Endocrinol Metabol 1999 84 2429 2433 10.1210/jc.84.7.2429
16. An insertion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. A Snapir, P Heinonen, TP Tuomainen, P Alhopuro, MK Karvonen, Tα Lakka, K Nyyssonen, R Salonen, J Kauhanen, VP Valkonen, U Pesonen, M Koulu, M Scheinin, JT Salonen, J Am Coll Cardiol 2001 37 1516 1522 10.1016/S0735-1097(01)01201-3 11345359 (Pubitemid 32385983)
17. Variation in the alpha2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death. A Snapir, J Mikkelsson, M Perola, A Penttila, M Scheinin, PJ Karhunen, J Am Coll Cardiol 2003 41 190 194 10.1016/S0735-1097(02)02702-X 12535806 (Pubitemid 36092182)
18. Deletion polymorphism in the alpha2B-adrenergic receptor gene is associated with flow-mediated dilatation of the brachial artery. P Heinonen, L Jartti, MJ Jarvisalo, U Pesonen, JA Kaprio, T Ronnemaa, OT Raitakari, M Scheinin, Clin Sci 2002 103 517 524 10.1042/CS20020097 12401126 (Pubitemid 35305637)
19. Job strain, decision latitude and alpha2B-adrenergic receptor polymorphism significantly interact, and associate with high blood pressures in men. B Ohlin, G Berglund, PM Nilsson, O Melander, J Hypertension 2007 25 1613 1619 10.1097/HJH.0b013e3281ab6c7d (Pubitemid 47056567)
20. Physical activity, diet and incident diabetes in relation to an ADRA2B Polymorphism. DE Laaksonen, N Siitonen, J Lindstrom, JG Eriksson, P Reunanen, J Tuomilehto, M Uusitupa, Med Sci Sports Exerc 2007 39 2227 232
21. Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and type 2 diabetes. The Finnish Diabetes Prevention Study. N Siitonen, J Lindstom, J Eriksson, TT Valle, H Hamalainen, P IIanne-Parikka, S Keinanen-Kiukaanniemi, J Tuomilehto, M Laakso, M Uusitupa, Diabetologia 2004 47 1416 1424 10.1007/s00125-004-1462-z 15309292 (Pubitemid 39232428)
22. Alpha2B-adrenergic receptor deletion polymorphism and cardiac autonomic nervous system responses to exercise in obese women. LM Ueno, ES Frazzatto, LT Batalha, IC Trombetta, M do Socorro Brasileiro, C Irigoyen, PC Brum, SM Villares, CE Negrao, Intl J Obes 2006 30 214 220 10.1038/sj.ijo.0803140 (Pubitemid 43237673)
23. A deletion in the alpha2B-adrenergic receptor gene and automatic nervous function in central obesity. K Sivenius, L Niskanen, M Laakso, M Uusitupa, Obes Res 2003 11 962 970 10.1038/oby.2003.133 12917501 (Pubitemid 41137508)
24. Alpha(2)-Adrenergic receptor subtype-specific activation of NF-kappaB in PC12 cells. A Lymperopoulos, G Karkoulias, WJ Koch, CS Flordellis, NeurosciLett 2006 402 210 215 (Pubitemid 43850153)
25. 2-adrenergic receptors. S Taraviras, T Olli-Lahdesmaki, A Lymperopoulos, D Charitonidou, E Mavroidis, J Kallio, M Scheinin, C Flordellis, Eur J Cell Biol 2002 81 363 374 10.1078/0171-9335-00250 12113477 (Pubitemid 34692947)
26. Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. III. Coupling of alpha 2-adrenergic receptor subtypes in a cell type-specific manner. E Duzic, SM Lanier, J Biol Chem 1992 267 24045 24052 1358886 (Pubitemid 23088223)